Avinger (NASDAQ:AVGR) announced its quarterly earnings results on Monday, May 14th. The medical device company reported ($5.37) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.84) by ($4.53), Bloomberg Earnings reports. The business had revenue of $1.81 million for the quarter.
Shares of Avinger opened at $1.29 on Wednesday, MarketBeat reports. Avinger has a 52-week low of $0.95 and a 52-week high of $38.40. The firm has a market capitalization of $7.48 million, a price-to-earnings ratio of -0.02 and a beta of 0.55.
Separately, Ladenburg Thalmann assumed coverage on shares of Avinger in a report on Friday, March 9th. They issued a “buy” rating on the stock.
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.